News Release: Research , School of Medicine

Sep. 7,  2010

Emory Eye Center to Host Inaugural Southeastern Ocular Oncology/Pathology Seminar

Emory Eye Center will host the inaugural Southeastern Ocular Oncology/Pathology seminar (SEOP) on Friday, Oct. 29, at the Eye Center’s Calhoun Auditorium within the Learning Resources Center. The meeting will take place from 8 a.m. to 5 p.m.

Hans Grossniklaus, MD, MBA, F. Phinizy Calhoun Jr. Professor of Ophthalmology and director of the L.F. Montgomery Pathology Laboratory and the section of Ocular Oncology/Ophthalmic Pathology, will host the seminar.

The SEOP meeting will provide a forum for dissemination of knowledge in ocular oncology. “I am very excited about this inaugural SEOP meeting which provides a forum for discussing current concepts in ocular oncology including diagnosis, medical and surgical management,” says Grossniklaus. “We have an outstanding guest speaker and three panelists who will undoubtedly add great value to this event.”

“This meeting brings the brightest ocular oncologists in the country to Emory for open and academic discussion of the management of ocular oncology cases, in a very clinical format,” says Timothy W. Olsen, MD, director of Emory Eye Center. “What better organizer than an ophthalmic pathologist such as Dr. Grossniklaus – someone who has seen it all.”

The F. Phinizy Calhoun Jr. Lecture will be presented by David Wilson, MD, director of the Casey Eye Institute, Oregon Health & Science University (Portland), and an ocular oncologist. His topic will be “Intraocular Lymphoma.”

The keynote lecture will be followed by sessions on retinoblastoma, melanoma, and other ocular tumors including conjunctival tumors and eyelid/orbital tumors. Jerry Shields MD, and Carol Shields MD, from Wills Eye Institute, Philadelphia, and Matthew Wilson, MD, from the University of Tennessee, Memphis/St Jude Hospital, will serve as panelists. Participants are encouraged to bring in their own cases for discussion. SEOP discussions will center on diagnosis, medical and surgical management.

Additionally, the Ocular Oncology/Pathology service at the Emory Eye Center, including Chris Bergstrom, MD, OD; Dr. Grossniklaus; Baker Hubbard, MD; and Jill Wells, MD, will participate in case presentations and discussions. The Eye Center’s Oculoplastics service including Ted Wojno, MD, and Joseph Walrath, MD, will also participate.

The mission of Emory Eye Center’s Ocular Oncology/Pathology service is a comprehensive team approach where patients receive optimal care for ocular tumors. That includes evaluation, medical management, surgical management, and oncology care in conjunction with Winship Cancer Institute, an NCI-designated (National Cancer Institute) center at Emory University, in addition to access to currently available clinical trials.

Grossniklaus, who also serves at Winship and is the principal investigator of an NCI-institute R01 grant, explains that the Eye Center’s Ocular Oncology/ Ophthalmic Pathology service also includes a regular Tumor Board, which discusses recommendations for treatment for individual patients.

CME credit is offered for SEOP, and the registration cost includes lunch and a reception following the event. For registration information, go to www.emory.edu/CME.

For general information, go to: http://www.eyecenter.emory.edu/events/seop.htm

###

The Robert W. Woodruff Health Sciences Center of Emory University is an academic health science and service center focused on missions of teaching, research, health care and public service.

Learn more about Emory’s health sciences:
Blog: http://emoryhealthblog.com
Twitter: @emoryhealthsci
Web: http://emoryhealthsciences.org

News Release Tools

  • Print

News Releases

The news release you are currently viewing is part of an archive of Emory health sciences press releases, dating Sept. 2008 - Dec. 2011.



To View Current Releases


Emory News Center

Emory News Center



To View News Archives


News Archives

News Archives